Source: Virtual Congress 2021 – COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
B. Karaborni (La Marsa, Tunisia), H. Cherif (La Marsa, Tunisia), A. Boufaress (La Marsa, Tunisia), Z. Teyeb (La Marsa, Tunisia), S. Belakhel (La Marsa, Tunisia), M. Bougacha (La Marsa, Tunisia), M. Triki (La Marsa, Tunisia), F. Yangui (La Marsa, Tunisia), M. Charfi (La Marsa, Tunisia). CT quantification of lung lesions as a prognostic factor for severe lung damage in COVID-19 patients. 3477

Member's Comments

No comment yet.

Related content which might interest you: Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 CT densitometry as a predictor of pulmonary function in lung cancer patients Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease Year: 2011 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension. Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 The prognostic factor of lung abscess Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Lung cancer in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 1216-1219 Year: 2001 The value of lung perfusion scintigraphy in the prediction of postoperative function in lung cancer Source: Annual Congress 2004 - Assessment of lung function before resection of lung cancer Year: 2004 Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function Source: Eur Respir J 2002; 20: Suppl. 38, 209s Year: 2002 A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 The correlation between pathological findings of transbronchial lung cryobiopsy and high resolution CT morphology for diffuse parenchymal lung disease patients Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Candidacolonization in lung cancer patients and its role as a prognostic factor for infection occurrence during hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 433s Year: 2003 The benefit of surgical lung biopsy in diagnosis and prognosis of diffuse infiltrative lung disease Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery Year: 2007 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Prognostic factors in patients with lung cancer and brain metastases at presentation Source: Eur Respir J 2007; 30: Suppl. 51, 670s Year: 2007 The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002 Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases. Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Changes in pulmonary 18F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010